Header

UZH-Logo

Maintenance Infos

Pharmacovigilance für Tierarzneimittel in der Schweiz


Müntener, C R; Gassner, B; Demuth, D C; Althaus, F R; Zwahlen, R (2004). Pharmacovigilance für Tierarzneimittel in der Schweiz. Schweizer Archiv für Tierheilkunde, 146(11):499-505.

Abstract

Pharmacovigilance is a system concerned with the acquisition, evaluation and classification of informations about suspected adverse drug reactions (SADR). Such a system was developed in Switzerland under the supervision of Swissmedic after the introduction of the federal law on therapeutic products on January 1st 2002. By sending declarations about SADRs, veterinary practitioners play a central role in this scheme. The reports are processed according to international standards (ABON) and provide useful hints to enhance the safety of drug usage by both patients and owners. The system acquired 58 reports in its first complete year of operation (2003). Analysis of these reveals that trends observed in foreign countries are also applicable to Switzerland: most of the reports concerned the use of antiparasitic or antibiotic drugs in small animals. The first year also revealed a high percentage of declarations coming from the pharmaceutical companies and the authors would therefore like to encourage practitioners to take a more active part in this scheme.

Abstract

Pharmacovigilance is a system concerned with the acquisition, evaluation and classification of informations about suspected adverse drug reactions (SADR). Such a system was developed in Switzerland under the supervision of Swissmedic after the introduction of the federal law on therapeutic products on January 1st 2002. By sending declarations about SADRs, veterinary practitioners play a central role in this scheme. The reports are processed according to international standards (ABON) and provide useful hints to enhance the safety of drug usage by both patients and owners. The system acquired 58 reports in its first complete year of operation (2003). Analysis of these reveals that trends observed in foreign countries are also applicable to Switzerland: most of the reports concerned the use of antiparasitic or antibiotic drugs in small animals. The first year also revealed a high percentage of declarations coming from the pharmaceutical companies and the authors would therefore like to encourage practitioners to take a more active part in this scheme.

Statistics

Citations

Dimensions.ai Metrics
13 citations in Web of Science®
11 citations in Scopus®
2 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

2 downloads since deposited on 30 Mar 2009
0 downloads since 12 months
Detailed statistics

Additional indexing

Other titles:Pharmacovigilance for veterinary drugs in Switzerland
Item Type:Journal Article, refereed, original work
Communities & Collections:05 Vetsuisse Faculty > Institute of Veterinary Pharmacology and Toxicology
Dewey Decimal Classification:570 Life sciences; biology
Language:German
Date:2004
Deposited On:30 Mar 2009 15:07
Last Modified:19 Feb 2018 20:31
Publisher:Hans Huber
ISSN:0036-7281
OA Status:Closed
Publisher DOI:https://doi.org/10.1024/0036-7281.146.11.499
PubMed ID:15581284

Download